Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

The stock's fall snapped a four-day winning streak.

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Just don't jump to conclusions about a stock's probable future based on its recent (and not-so-recent) past, even when that historical weakness is as dramatic and prolonged as Pfizer's has been.

Value investors rely on traditional forms of analysis on key valuation ... value stocks on the market today. One stock to keep an eye on is Pfizer (PFE). PFE is currently sporting a Zacks Rank ...

Pfizer also announced a hefty total dividend of Rs 165 per equity share for FY25. This includes a final dividend of Rs 35 per ...

But I actually see this as a risk factor since according to my earlier analysis, Pfizer ... company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is ...

analysis of the Phase 3... By Nate Raymond (NSE:RYMD) (Reuters) - Pfizer (NYSE:PFE) has resolved a lawsuit by a conservative group that alleged that a... Investing.com - Healthcare and vaccine ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.